パーキンソン病における脳深部刺激療法の世界市場の規模は、2024年に9億960万ドルと評価され、2025年から2030年にかけて10.1%のCAGRで成長すると予測されます。パーキンソン病やその他の神経疾患の有病率の増加によって、脳深部刺激療法 (DBS) などの高度な治療オプションが必要となることがこの市場の成長要因となっています。さらに、パーキンソン病にかかりやすい高齢者人口の増加が、市場の成長に大きく貢献しています。DBSデバイスの技術的進歩 (微小電極設計の改善やロボット支援埋め込みなど) により、治療の有効性と安全性が向上しています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Insights
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. Deep Brain Stimulation In Parkinson’s Disease Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Deep Brain Stimulation In Parkinson’s Disease Market: Product Outlook Estimates & Forecasts
4.1. Deep Brain Stimulation In Parkinson’s Disease Market: Product Movement Analysis, 2024 & 2030
4.1.1. Single-channel
4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.1.2. Dual-channel
4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Deep Brain Stimulation In Parkinson’s Disease Market: End Use Outlook Estimates & Forecasts
5.1. Deep Brain Stimulation In Parkinson’s Disease Market: End Use Movement Analysis, 2024 & 2030
5.1.1. Hospitals
5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.1.2. Neurology Clinics
5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.1.3. Ambulatory Surgical Centers
5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.1.4. Research Centers
5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Deep Brain Stimulation In Parkinson’s Disease Market Regional Outlook Estimates & Forecasts
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. UK
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. France
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Italy
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Spain
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.10. Norway
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework
6.5.10.3. Competitive insights
6.5.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. Japan
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Indonesia
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.8. Australia
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive insights
6.6.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.9. Philippines
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework
6.6.9.3. Competitive insights
6.6.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.10. Malaysia
6.6.10.1. Key country dynamics
6.6.10.2. Regulatory framework
6.6.10.3. Competitive insights
6.6.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.11. Singapore
6.6.11.1. Key country dynamics
6.6.11.2. Regulatory framework
6.6.11.3. Competitive insights
6.6.11.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.4. Colombia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive insights
6.7.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.5. Chile
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive insights
6.7.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.6. Venezuela
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive insights
6.7.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. Middle East & Africa
6.8.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Turkey
6.8.5.1. Key country dynamics
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.6. Iran
6.8.6.1. Key country dynamics
6.8.6.2. Regulatory framework
6.8.6.3. Competitive insights
6.8.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.7. Kuwait
6.8.7.1. Key country dynamics
6.8.7.2. Regulatory framework
6.8.7.3. Competitive insights
6.8.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Vendor Landscape
7.2.1. Company categorization
7.2.2. List of Key Distributors and Channel Partners
7.2.3. List of Potential Customers/End Users
7.3. Competitive Dynamics
7.3.1. Competitive Benchmarking
7.3.2. Strategy Mapping
7.3.3. Heat Map Analysis
7.4. Company Profiles/Listing
7.4.1. ABBOTT
7.4.1.1. Participant’s overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Medtronic
7.4.2.1. Participant’s overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Boston Scientific Corporation
7.4.3.1. Participant’s overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
List of Tables
Table 1. List of abbreviations
Table 2. Deep brain stimulation in Parkinson’s disease market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
Table 3. Deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 4. Deep brain stimulation in Parkinson’s disease market estimates and forecasts, by region, 2018 - 2030 (USD Million)
Table 5. North America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 6. North America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 7. North America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 8. U.S. deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 9. U.S. deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 10. Canada deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 11. Canada deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 12. Mexico deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 13. Mexico deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 14. Europe deep brain stimulation in Parkinson’s disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 15. Europe deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16. Europe deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 17. UK deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 18. UK deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19. Germany deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20. Germany deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21. France deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 22. France deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23. Italy deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24. Italy deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 25. Spain deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 26. Spain deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27. Denmark deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28. Denmark deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29. Sweden deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 30. Sweden deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31. Norway deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32. Norway deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 33. Asia Pacific deep brain stimulation in Parkinson’s disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 34. Asia Pacific deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 35. Asia Pacific deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 36. Japan deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 37. Japan deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 38. China deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 39. China deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 40. India deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 41. India deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 42. Indonesia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 43. Indonesia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 44. South Korea deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 45. South Korea deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 46. Thailand deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 47. Thailand deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 48. Australia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 49. Australia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 50. Philippines deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 51. Philippines deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 52. Malaysia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 53. Malaysia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 54. Singapore deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 55. Singapore deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 56. Latin America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 57. Latin America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 58. Latin America deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 59. Brazil deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 60. Brazil deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 61. Argentina deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 62. Argentina deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63. Colombia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 64. Colombia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 65. Chile deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 66. Chile deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 67. Venezuela deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 68. Venezuela deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 69. Middle East & Africa deep brain stimulation in Parkinson’s disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 70. Middle East & Africa deep brain stimulation in Parkinson’s disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 71. Middle East & Africa deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 72. South Africa deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73. South Africa deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 74. Saudi Arabia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75. Saudi Arabia deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 76. UAE deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 77. UAE deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 78. Turkey deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79. Turkey deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 80. Iran deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 81. Iran deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 82. Kuwait deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 83. Kuwait deep brain stimulation in Parkinson’s disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Market snapshot
Fig. 6 Segmental outlook- Product, and End Use
Fig. 7 Competitive outlook
Fig. 8 Value chain analysis
Fig. 9 Market dynamics
Fig. 10 Porter’s analysis
Fig. 11 PESTEL analysis
Fig. 12 Deep brain stimulation In Parkinson’s disease market, by product: Key takeaways
Fig. 13 Deep brain stimulation In Parkinson’s disease market, by product: Market share, 2024 & 2030
Fig. 14 Deep brain stimulation In Parkinson’s disease market, by end use: Key takeaways
Fig. 15 Deep brain stimulation In Parkinson’s disease market, by end use: Market share, 2024 & 2030
Fig. 16 Deep brain stimulation In Parkinson’s disease market, by region: Key takeaways
Fig. 17 Deep brain stimulation In Parkinson’s disease market, by region: Market share, 2024 & 2030